Literature DB >> 23508978

Dyslipidemia and non-alcoholic fatty liver disease.

Palaniappan Manickam, Rajeev Sudhakar.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23508978     DOI： 10.1007/s10620-013-2577-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  8 in total

1.  The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Anna Mae Diehl; Elizabeth M Brunt; Kenneth Cusi; Michael Charlton; Arun J Sanyal
Journal:  Gastroenterology       Date:  2012-05-15       Impact factor: 22.682

2.  Comparative prognostic utility of conventional and novel lipid parameters for cardiovascular disease risk prediction: do novel lipid parameters offer an advantage?

Authors:  Palaniappan Manickam; Ankit Rathod; Sidakpal Panaich; Pawan Hari; Vikas Veeranna; Apurva Badheka; Sony Jacob; Luis Afonso
Journal:  J Clin Lipidol       Date:  2010-12-17       Impact factor: 4.766

Review 3.  Can NASH be diagnosed, graded, and staged noninvasively?

Authors:  Garfield A Grandison; Paul Angulo
Journal:  Clin Liver Dis       Date:  2012-06-26       Impact factor: 6.126

4.  Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease.

Authors:  Munkhzul Otgonsuren; Maria Stepanova; Lynn Gerber; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2012-11-10       Impact factor: 3.199

Review 5.  Prevalence, gender, ethnic variations, and prognosis of NASH.

Authors:  Etsuko Hashimoto; Katsutoshi Tokushige
Journal:  J Gastroenterol       Date:  2010-09-16       Impact factor: 7.527

6.  The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.

Authors:  E E Powell; W G Cooksley; R Hanson; J Searle; J W Halliday; L W Powell
Journal:  Hepatology       Date:  1990-01       Impact factor: 17.425

7.  Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy.

Authors:  Ferdinand W N M Wit; Gerrit Jan Weverling; Jan Weel; Suzanne Jurriaans; Joep M A Lange
Journal:  J Infect Dis       Date:  2002-06-14       Impact factor: 5.226

8.  The utility of radiological imaging in nonalcoholic fatty liver disease.

Authors:  Sherif Saadeh; Zobair M Younossi; Erick M Remer; Terry Gramlich; Janus P Ong; Maja Hurley; Kevin D Mullen; James N Cooper; Michael J Sheridan
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682
  8 in total
  1 in total

1.  Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis.

Authors:  Yun-Hua Li; Lu-Hua Yang; Kai-Hui Sha; Tong-Gang Liu; Li-Guo Zhang; Xian-Xian Liu
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.